USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/4118
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSamohvalov, Elena
dc.date.accessioned2019-06-25T12:51:28Z-
dc.date.available2019-06-25T12:51:28Z-
dc.date.issued2010
dc.identifier.citationSAMOHVALOV, Elena. Aplicarea criteriilor sindromului antifosfolipidic obstetrical. In: Anale Științifice ale USMF “Nicolae Testemiţanu”. Ed. a 11-a. Chișinău: CEP Medicina, 2010, vol. 3: Probleme actuale în medicina internă, pp. 86-91.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/4118-
dc.descriptionCatedra Medicină Internă nr.3 USMF ”Nicolae Testemiţanu”en_US
dc.description.abstractThe antiphospholipid syndrome (APS) is characterized by recurrent arterial and/or venous thrombosis and pregnancy morbidity manifested by early or late losses. Laboratory diagnosis of APS relies on the demonstration of a positive test for antiphospholipid antibodies (aPL). In clinical practice, the gold standard tests are those that detect anticardiolipin antibodies (aCL) and/or the lupus anticoagulant (LA). Although other specificities for aPL have been described their clinical utility and standardization has still to be established. Persistence of aPL positive tests must be demonstrated, and other causes and underlying factors considered. Correct identification of patients with APS is important, because prophylactic anticoagulant therapy can prevent thrombosis from recurring, and treatment of affected women during pregnancy can improve fetal and maternal outcome. Studierea manifestărilor sindromului antifosfolipidic obstetrical (SAFLo) – afecţiune care se prezintă clinic cu recurenţe de tromboze venoase sau arteriale şi/sau patologie obstetricală. Confirmare de laborator în SAFL sunt nivelurile ridicate de anticorpi anticardiolipinici şi/sau anticoagulantul lupic. Sindromul antifosfolipidic reprezintă un domeniu de interes susţinut şi o problemă cu importante valenţe medico-sociale. Utilizarea criteriilor de diagnostic în SAFLo presupune diagnostic precoce şi tratament adecvat.en_US
dc.language.isoroen_US
dc.publisherCEP "Medicina"en_US
dc.subject.meshAntiphospholipid Syndromeen_US
dc.subject.meshPregnancyen_US
dc.subject.meshAntiphospholipid Syndrome – diagnosisen_US
dc.subject.meshAntiphospholipid Syndrome – prevention and controlen_US
dc.subject.meshAntibodies, Anticardiolipinen_US
dc.subject.meshThrombosisen_US
dc.titleAplicarea criteriilor sindromului antifosfolipidic obstetricalen_US
dc.typeArticleen_US
Appears in Collections:Cardiologie, reumatologie, nefrologie

Files in This Item:
File Description SizeFormat 
APLICAREA_CRITERIILOR_SINDROMULUI_ANTIFOSFOLIPIDIC_OBSTETRICAL.pdf622.55 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback